St. Stamford Modern Cancer Hospital Guangzhou
A JCI-accredited cancer specialty hospital in Guangzhou, founded in 2005 as a Singapore-China joint venture between Singapore Perennial Real Estate Holdings Limited and Boai Medical Group. The hospital is positioned around 18 advanced minimally invasive cancer technologies β including DEB-TACE, Combined Knife (cryoablation), Nanoknife (irreversible electroporation), particle implantation seed therapy, photodynamic therapy, microwave ablation, radiofrequency ablation and photon knife β integrated with traditional Chinese medicine alongside Western medicine, supported by a multidisciplinary MDT team and an international patient operation serving families from Southeast Asia, MENA and beyond.
About St. Stamford Modern Cancer Hospital Guangzhou
St. Stamford Modern Cancer Hospital Guangzhou (MCHG, also previously known simply as Modern Cancer Hospital Guangzhou) is a cancer specialty hospital located at the foot of Baiyun Mountain in Guangzhou, Guangdong Province, China. The hospital was founded in 2005 as a joint venture between Singapore Perennial Real Estate Holdings Limited and Boai Medical Group (one of China's larger private medical investment groups). The hospital is managed under Chinese health authority oversight and operates with a total construction area of approximately 180,000 square metres, 180 approved beds with 293 beds in actual operation, and over 400 employees. In October 2014, the hospital was first accredited by Joint Commission International (JCI), with re-accreditation passed in 2017 β making it among a small number of JCI-accredited cancer-specialty hospitals in mainland China.
The hospital's clinical positioning rests on a particular treatment philosophy: 18 minimally invasive cancer therapies combined with traditional Chinese medicine (TCM) alongside Western medicine, delivered through a multidisciplinary MDT structure. The 18 minimally invasive technologies include DEB-TACE (drug-eluting bead transarterial chemoembolisation) and drug-loaded microspheres for liver and other vascular tumours; Combined Knife (a composite cryogenic freezing system using liquid nitrogen for cold and heat ablation); Nanoknife (irreversible electroporation, particularly for tumours near hepatic hilar regions, gallbladder, bile ducts, pancreas and ureter where traditional ablation is risky); particle implantation (radioactive iodine-125 seed implantation) including 3D particle implantation; photodynamic therapy; photon knife therapy; microwave ablation and radiofrequency ablation; cryotherapy; thermal therapy; gene targeted therapy; chemoradiation seed implantation; green chemotherapy; immune cell therapy; breast reconstruction; and TCM-Western combination therapy. The hospital reports having performed over 30,000 minimally invasive cancer procedures.
The hospital is internationally positioned with substantial reach across Southeast Asia, with branch offices established in Malaysia, Indonesia, the Philippines, Vietnam, Thailand, Cambodia, Bangladesh and other countries, and active patient flow from across Southeast Asia, MENA, Bangladesh, and beyond. The hospital is a member of the Union for International Cancer Control (UICC), the China Anti-Cancer Association, and the Joint Commission on Accreditation of Healthcare Organizations affiliate network, and has formal collaborations with the National University Hospital of Singapore. Senior faculty include Professor Zhang Fujun (Chief Scientist of the Department of Minimally Invasive Tumor) and Professor Song Shijun (40+ years of oncology clinical experience, formerly Deputy Director of Medical Oncology at the Third Affiliated Hospital of Xinxiang Medical College, with expertise in thoracic tumours including oesophageal cancer, lung cancer, breast cancer and lymphoma).
CancerFax works with patients considering St. Stamford Modern Cancer Hospital Guangzhou where minimally invasive interventional oncology β particularly DEB-TACE for hepatocellular carcinoma and other liver tumours, Nanoknife for pancreatic and other anatomically difficult tumours, cryoablation and microwave/radiofrequency ablation for selected solid tumours, and iodine-125 particle implantation for localised disease β is a clinically appropriate component of the treatment plan. Our coordination service includes an honest pre-travel review of whether the proposed minimally invasive approach is aligned with international cancer treatment guidelines for the specific diagnosis and stage, and we will openly discuss alternative pathways including Sun Yat-sen University Cancer Center (Guangzhou, China's national flagship for solid tumour cancer in the South), Cancer Hospital of the Chinese Academy of Medical Sciences in Beijing (China's national cancer flagship), Shanghai GoBroad Cancer Hospital, Clifford Hospital (Guangzhou, integrative oncology with HIFU and Gamma Knife), and major Indian and Singaporean alternatives. For haematological malignancies requiring CAR T-cell therapy or HSCT, we route to dedicated centres such as Beijing GoBroad Boren Hospital, Lu Daopei Hospital and IHBDH Tianjin rather than MCHG. CancerFax charges patients nothing for this coordination.
| Hospital at a Glance | |
|---|---|
| Country | China |
| City | Guangzhou, Guangdong Province (at the foot of Baiyun Mountain) |
| Established | 2005 |
| Hospital Type | Private Cancer Specialty Hospital Β· Singapore-China Joint Venture Β· Boai Medical Group affiliated Β· Managed under Chinese health authority oversight |
| Accreditation | Joint Commission International (JCI) β first accredited October 2014, re-accredited 2017; β VERIFY: current JCI accreditation status (latest cycle) with the hospital before publishing; Member of UICC, China Anti-Cancer Association, China Ministry of Health-designated hospital |
| Beds | 180 approved beds, 293 actual operational beds; total construction area 180,000 sqm; 400+ employees |
| Annual Patient Activity | Reports over 30,000 cumulative minimally invasive cancer procedures; β VERIFY: current annual cancer patient volume and procedure mix with the hospital |
| Clinical Focus | Minimally invasive interventional oncology (18 modalities including DEB-TACE, Nanoknife, cryoablation, particle implantation, photodynamic therapy); integrated TCM-Western cancer care; multidisciplinary MDT structure; international patient operation across Southeast Asia and MENA |
Why Patients Choose St. Stamford Modern Cancer Hospital Guangzhou
The hospital's distinct value for international cancer patients lies in its concentrated expertise in minimally invasive interventional oncology, JCI-accredited international service standards, and an established multi-country international patient operation that has served patients from across Southeast Asia, Bangladesh, MENA and beyond for nearly two decades.
Cancer Types Treated and Clinical Programmes
St. Stamford Modern Cancer Hospital Guangzhou treats a broad range of solid tumours with its minimally invasive interventional approach, with particular concentration on cancers where DEB-TACE, Nanoknife, cryoablation and particle implantation are clinically appropriate components of the treatment plan.
Advanced Treatment Capabilities
Key Specialists at St. Stamford Modern Cancer Hospital Guangzhou
The hospital is staffed by a multidisciplinary clinical team across surgical, medical, interventional radiology, radiation oncology, TCM and supportive care specialties. Senior faculty include Professor Zhang Fujun, Chief Scientist of the Department of Minimally Invasive Tumor since 2016, and Professor Song Shijun, a senior chief physician with more than 40 years of clinical oncology experience, formerly Deputy Director of the Medical Oncology Department at the Third Affiliated Hospital of Xinxiang Medical College, specialising in chemotherapy, minimally invasive therapy, biotherapy and targeted therapy for thoracic tumours (oesophageal cancer, lung cancer, breast cancer) and lymphoma. The hospital has also engaged collaborations including interviews with Mayo Clinic and a strategic partnership with the National University Hospital of Singapore, and academician Fan Daiming of the Chinese Academy of Engineering has inscribed for the hospital's research institute.
Patient care is structured through multidisciplinary medical team (MDT) consultations, bringing together specialists from different departments to formulate personalised treatment plans for each case β a departure from the traditional single-oncologist model. International patients are managed through dedicated branch offices in their home country (Malaysia, Indonesia, Philippines, Vietnam, Thailand, Cambodia, Bangladesh and other locations) plus an in-hospital international service team. Patients seeking specific physician consultations or focused multidisciplinary second opinions can submit their request through CancerFax β we work with MCHG to confirm in advance which named senior consultant will be assigned to the case, and we will openly discuss whether parallel review at Sun Yat-sen University Cancer Center (Guangzhou's national flagship for solid tumour care), Cancer Hospital of CAMS (Beijing, national cancer flagship), Shanghai GoBroad Cancer Hospital, Clifford Hospital, or international centres may be more appropriate for the specific clinical situation before any travel commitment.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission.
Clinical Infrastructure and Treatment Technology
St. Stamford Modern Cancer Hospital Guangzhou's 180,000 square metre campus at the foot of Baiyun Mountain integrates inpatient care, outpatient consultation, latest-generation diagnostic imaging, dedicated minimally invasive procedure suites, and an integrative TCM-Western treatment infrastructure designed around its 18-modality minimally invasive cancer therapy platform.
- DEB-TACE (drug-eluting bead transarterial chemoembolisation) and drug-loaded microspheres for liver and vascular tumours
- Nanoknife (irreversible electroporation) for pancreatic, hepatic hilar, gallbladder, bile duct, pancreatic and ureteric tumours where traditional ablation is risky
- Combined Knife composite cryogenic ablation, microwave ablation, radiofrequency ablation and cryotherapy
- Radioactive iodine-125 particle implantation seed therapy including 3D particle implantation for localised disease
- Chemoradiation seed implantation; photodynamic therapy; photon knife therapy
- Latest-generation PET-CT, MRI and CT diagnostic imaging with reported rapid turnaround (complex examination in 3-4 days; biopsy results in 8-9 days)
- Green chemotherapy programme designed to minimise systemic chemotherapy toxicity
- Targeted therapy and gene targeted therapy across DCGI- and FDA-approved Chinese oncology formulary
- Immune cell therapy programme (DC-CIK and related); β VERIFY: specific commercial CAR T-cell therapy product availability with the hospital (the highest-volume CancerFax CAR-T pathway remains Beijing GoBroad Boren Hospital)
- Integrated traditional Chinese medicine alongside Western medicine, with TCM positioned as supportive care for symptom management, side-effect reduction and recovery support
- Standard rooms, VIP two-suite rooms (Western-style and Chinese-style), VIP deluxe three-suite rooms across the 180,000 sqm Baiyun Mountain campus
- On-campus nutrition centre, coffee bar, sky garden, 24-hour family companion policy and Singapore-derived 6S management standards
International Patient Support at St. Stamford Modern Cancer Hospital Guangzhou
St. Stamford Modern Cancer Hospital Guangzhou operates one of the most extensive international patient infrastructures of any Chinese cancer hospital, with branch offices established across Southeast Asia and beyond β in Malaysia (Kuala Lumpur), Indonesia, the Philippines (Manila), Vietnam (Ho Chi Minh, Hanoi), Thailand, Cambodia, Bangladesh, and additional offices serving the UAE, Saudi Arabia and Egypt markets.
What to Prepare Before Traveling
- arrow_rightShare complete pathology reports, biopsy slides where requested for re-review, recent CT, PET-CT and MRI imaging, molecular profiling and a current medication list (in English or Chinese) with CancerFax at least one to two weeks before any planned MCHG consultation. CancerFax will use these to assess whether the proposed minimally invasive approach is clinically appropriate for the diagnosis and stage, and where guideline-recommended first-line treatment (surgery, chemotherapy, radiotherapy, immunotherapy) has not yet been adequately attempted, we will discuss this openly before travel.
- arrow_rightApply for an appropriate Chinese visa (M for medical or L for tourist) at your nearest Chinese consulate. MCHG can issue an official invitation letter for the patient and accompanying family members; the hospital's in-country branch offices (Malaysia, Indonesia, Philippines, Vietnam, Thailand, Cambodia, Bangladesh) can directly facilitate visa documentation for patients from those markets.
- arrow_rightPlan travel via Guangzhou Baiyun International Airport (CAN), which has direct flights from most Southeast Asian and MENA cities, or via Hong Kong International Airport (HKG) with onward ground transit of 1-2 hours into Guangzhou. Allow at least one to two weeks for initial MDT consultation, minimally invasive procedure planning and any procedure (which is typically a same-day or short-stay intervention), with longer stays for combined treatment courses or post-procedure follow-up imaging.
St. Stamford Modern Cancer Hospital Guangzhou can be contacted directly through moderncancerhospitalmy.com (Malaysia patient portal), asiancancer.com (main English portal) or the relevant in-country branch office. CancerFax coordinates all communication on the patient's behalf in Mandarin Chinese, provides independent clinical assessment of whether the proposed minimally invasive approach is appropriate for the case, manages comparative review with alternative Chinese and international cancer pathways, and remains the single point of contact through treatment and follow-up at no cost to the patient.
Patient Facilities and Accommodation at St. Stamford Modern Cancer Hospital Guangzhou
The hospital's 180,000 square metre campus at the foot of Baiyun Mountain offers a deliberately restful environment with multiple room categories including standard rooms, VIP two-suite rooms in Western or Chinese styles and VIP deluxe three-suite rooms, supported by on-campus nutrition centre, coffee bar, sky garden and Singapore-derived hospital service standards.
Family members accompanying international patients can stay at hotels and serviced apartments near the Baiyun Mountain hospital campus or in central Guangzhou. The hospital's Singapore-derived 6S service model includes 24-hour family companion policy and deliberately restful campus surroundings. CancerFax can help plan budget-conscious extended-stay options for families travelling for combined treatment courses involving multiple minimally invasive procedures, post-procedure observation and follow-up imaging surveillance.
How to Reach St. Stamford Modern Cancer Hospital Guangzhou
St. Stamford Modern Cancer Hospital Guangzhou is located at the foot of Baiyun Mountain in Guangzhou, Guangdong Province, southern China. Guangzhou is one of China's most internationally connected cities and is reachable via direct flights from across Southeast Asia, MENA and beyond.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
St. Stamford Modern Cancer Hospital Guangzhou β Patient Questions Answered
CancerFax acts as your single coordinator for the entire MCHG journey, with one important clinical screening step at the start. You begin by sharing your medical records β pathology, biopsy slides where re-review is requested, recent CT, PET-CT and MRI imaging, molecular profiling, prior treatment summaries β through our secure intake. Our clinical team reviews the case and provides an honest assessment of whether MCHG's minimally invasive approach (DEB-TACE, Nanoknife, cryoablation, particle implantation or similar) is genuinely the right clinical fit for your specific diagnosis and stage, or whether guideline-recommended first-line treatment (surgery, systemic chemotherapy, radiotherapy, immunotherapy at a national flagship like Sun Yat-sen University Cancer Center or Cancer Hospital of CAMS Beijing) is the more appropriate first step. We will tell you openly if MCHG is not the right destination for your cancer.
Where MCHG is genuinely the right fit β typically for patients with localised liver, lung, pancreatic, kidney, prostate, breast or other solid tumours where interventional ablation, embolisation or particle implantation is a clinically appropriate component of the treatment plan, or where systemic chemotherapy has caused unacceptable side effects and a less-toxic minimally invasive approach is being considered β CancerFax prepares your full pre-travel pack: the hospital's official cost estimate translated into English (shared with you without any CancerFax mark-up), Chinese visa documentation, accredited Chinese-English translation of your home-country reports, accommodation guidance near the Baiyun Mountain campus, and travel logistics via Guangzhou Baiyun or Hong Kong airports. We remain your single point of contact through admission, procedure, follow-up imaging and post-procedure surveillance. There is no fee to the patient for any of this coordination.
This is an important distinction that international patients often need clarified. Sun Yat-sen University Cancer Center (SYSUCC, also in Guangzhou) is China's national flagship for solid tumour care in southern China β a public-sector university-affiliated cancer hospital with the highest case volumes, broadest treatment range, world-leading expertise in nasopharyngeal carcinoma, and standard public-sector pricing. St. Stamford Modern Cancer Hospital Guangzhou is a different type of institution: a private Singapore-China joint venture cancer hospital, JCI-accredited, focused specifically on minimally invasive interventional oncology, with hotel-style accommodation and an international patient operation across Southeast Asia and MENA. These two hospitals serve different patient needs. For curative-intent first-line cancer treatment at a Chinese national flagship, SYSUCC is typically the right destination. For minimally invasive interventional procedures (DEB-TACE for liver cancer, Nanoknife for pancreatic cancer, ablation for localised disease) as part of a broader treatment plan, or for patients explicitly seeking an international-service JCI-accredited environment, MCHG is positioned distinctly. CancerFax can openly compare both options for your specific case before any travel commitment.
This is the most important clinical question for international patients considering MCHG, and CancerFax answers it honestly: it depends on the specific cancer type, stage and clinical situation. Several of MCHG's minimally invasive therapies are well-established components of international cancer treatment guidelines for specific indications β for example, DEB-TACE for intermediate-stage hepatocellular carcinoma (Barcelona Clinic Liver Cancer stage B), radiofrequency ablation and microwave ablation for small liver tumours, Nanoknife for selected pancreatic cancers where surgical resection is not possible and tumour location precludes traditional thermal ablation, cryoablation for selected localised prostate and lung tumours, and iodine-125 particle implantation for selected localised disease. However, minimally invasive approaches are rarely first-line treatment for early-stage curable cancers where surgery, radiotherapy and systemic chemotherapy or immunotherapy at a national flagship cancer hospital offer the best chance of cure. CancerFax provides an honest pre-travel review of whether the proposed minimally invasive approach is appropriate for your specific case based on international guidelines, and where it is not, we will recommend alternative pathways openly.
Yes. MCHG actively accepts foreign-language medical records and provides written opinions before any travel commitment, particularly through its in-country branch offices in Malaysia, Indonesia, the Philippines, Vietnam, Thailand, Cambodia and Bangladesh which can handle first-contact case review locally. The process involves submitting your scans, pathology reports, prior treatment summaries and current medication list. CancerFax facilitates this submission and follows up on your behalf to obtain a written opinion or preliminary treatment recommendation, alongside our own independent clinical assessment of whether the proposed approach is appropriate. CancerFax can also arrange parallel remote second opinions from Sun Yat-sen University Cancer Center, Cancer Hospital of CAMS, Shanghai GoBroad Cancer Hospital, Clifford Hospital or international centres where this would be clinically useful, so the family can make a well-informed decision before any international travel.
As a private Singapore-China joint venture cancer hospital, MCHG offers cancer treatment at substantially lower cost than equivalent care in Singapore, the UK, the US or Western Europe β often by a factor of three to five for comparable minimally invasive procedures and supportive care. Within China, MCHG's pricing as a private joint venture hospital is typically higher than public-sector flagships such as Sun Yat-sen University Cancer Center in Guangzhou or Cancer Hospital of CAMS in Beijing, which combine national-flagship clinical capability with subsidised public-sector pricing for eligible patients. For patients seeking value within China, public-sector flagships may offer lower cost; for patients seeking JCI-accredited international service standards, in-country branch office support across Southeast Asia, and concentrated minimally invasive procedural expertise, MCHG's pricing premium may be justified. CancerFax shares MCHG's official cost estimates with you at no extra charge and without any CancerFax mark-up, and we are happy to compare them openly with both Chinese and international alternatives before any decision is made.
Send Your Medical Reports to St. Stamford Modern Cancer Hospital Guangzhou via CancerFax
CancerFax reviews your records and provides an honest clinical assessment of whether MCHG's minimally invasive approach is the right fit for your specific cancer, compares MCHG against alternative Chinese cancer pathways including Sun Yat-sen University Cancer Center and Cancer Hospital of CAMS, and coordinates your consultation or remote second opinion in Guangzhou at no cost, with no obligation, and with full medical confidentiality throughout.